Evidence Based Medicine Jobs In Netherlands - 12 Job Positions Available

Job TitleClinical Development Scientist Job Description Job Responsibilities Owns and drives end‑to‑end clinical evidence strategy, defining and linking clinical need, value, TPP, claims, endpoints, and evidence to regulatory acceptance and post‑market requirements with full lifecycle traceability (AD →

Company Description Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and our environment safer, healthier and more sustainable. From the

At Johnson & Johnson,we believe health is everything. Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, andsolutions are personal.Through our

Job Title: Head of Legal – North Europe & Netherlands Location: Amsterdam, Netherlands About the Role As Head of Legal for North Europe & Netherlands within our Legal, Ethics, Business Integrity & Global Security team, youll

Job Purpose: You will serve as a trusted scientific advisor in our specialty care and immunology medical team in the Netherlands. In this role you will be responsible for the local medical strategy for chronic rhinosinusitis

Job grade: FGIV Internal job grade: FGIV Type of position: Contract agent Selection procedure reference: EMA/CA/11428 Job title: Communication Officer Talent Pool: FGIV Engagement, Communication, International and Institutional Affairs Deadline for applications: 31 July 2026 at

Location: Amsterdam, The Netherlands Start date: 15 September 2026 Duration: 5 months (with the possibility of extension) Working Pattern: Full-time, 40 hours per week About the job As a Medical Intern within Sanofis Oncology Medical Team,

Vaccines Activation Manager - Netherlands Location: Netherland Role Type: Field Role About the job The Vaccines Activation Manager (VAM) – Netherlands drives vaccine activation across both the private and public vaccination landscape. The role combines commercial

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors

Global Health Economics and Outcome Research - VIE Contract Location: Netherlands, Amsterdam Target start date: 01/01/2027 iMove, the Sanofi VIE Program, is available to citizens of the European Economic Area (EU + Norway, Liechtenstein and Iceland)